AstraZeneca Pharma Ind Share Price

₹ 6,529.00

+₹49.50 (0.76%)
1D
Last updated 09 Nov, 2026, 15:29 IST
NSE: ASTRAZEN
|
Pharmaceuticals

AstraZeneca Pharma Ind Share Price Today

As of 10 Nov 2026, AstraZeneca Pharma Ind share price is ₹6,529.00. The stock opened at ₹6,484.00, compared to its previous close of ₹6,479.50. During today's trading session, AstraZeneca Pharma Ind share price moved in the range of ₹6,401.00 to ₹6,530.00, with an average price of ₹6,465.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹5,640.00 and a high of ₹9,469.50. On the performance front, AstraZeneca Pharma Ind share price has declined by 23.30% over the last six months and is down 28.23% on a year-on-year basis.

Share price over the last 1 day rose from 6477.50 to 6529.00, ranging between 6401.00 and 6530.00.
₹6,401.00
0.76% up today
₹6,530.00
1D LOW
1D HIGH

AstraZeneca Pharma Ind Stock Insights

Stock Performance
OutperformingBeat Nifty by 0.06 % in last 1 month
Shareholding Pattern
DIIDII increased stake by 12.57%
Shareholding Pattern
FIIFII decreased stake by 1.50%
AstraZeneca Pharma Ind stock performance
Open₹6,484.00
High₹6,530.00
Low₹6,401.00
Prev. close₹6,479.50
AstraZeneca Pharma Ind trading activity
Volume10,012
Average traded price₹6,467.59
Last traded time03:29:54 09 Nov
Last traded quantity2
Circuit
L
H
₹5,212.00
₹7,817.00
52-week
L
H
₹5,640.00
₹9,469.50
Mkt Cap Cr
16,280.50
P/E
91.61
P/B
18.52
ROA
8.11%
ROE
20.22%
ROCE
25.24%
Quick Ratio
0.73
EV/EBITDA
58.03

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Astrazeneca Phar outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Astrazeneca Phar appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,57,073.3141.65.129.61%13.79%18.65%2.3124.07
Divis Laboratories3,07,147.1591.3317.0713.32%15.32%19.56%3.567.29
Torrent Pharmaceuticals1,81,473.5086.539.894.7%11.42%11.37%0.7534.68
Laurus Labs1,28,054.0096.1121.1311.58%22.11%20.91%0.6853.3
Zydus Lifesciences1,19,700.4628.134.357.63%15.1%14.86%0.9116.02
Dr. Reddy's Laboratories1,15,685.1141.922.984.79%7.21%8.58%1.3519.31
Cipla1,13,589.0639.813.216.6%8.18%10.8%2.521.44
Mankind Pharma1,09,911.3048.566.257.82%12.76%14.68%0.7425.88
Aurobindo Pharma1,03,913.2526.72.76.46%10.13%12.76%1.1512.52
Lupin91,229.9517.623.8313.08%21.65%24.54%1.4210.23

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

AstraZeneca Pharma Ind Company Background

ISIN
INE203A01020
Sector Market Cap
₹ 16,280.50 Cr

AstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacturing, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. Its therapeutic offerings in CVRM business include heart failure, and chronic kidney disease indications for Forxiga (Dapagliflozin). Its approvals in oncology business include the use of Imfinzi (Durvalumab) in Biliary Tract Carcinoma, and use of Lynparza (Olaparib) in early breast cancer. The Company has a portfolio of oral antidiabetic drugs with presence in two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The Company’s DPP4 offering comprises of the brands of Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metformin).

AstraZeneca Pharma Ind Financial Highlights

  • Revenue: AstraZeneca Pharma Ind reported revenue of ₹2,304.07 crore in FY26 vs ₹1,756.92 crore in FY25. It showed an increase of 31.14% on a yearly basis.
  • Operating Profit: AstraZeneca Pharma Ind reported an operating profit of ₹252.20 crore in FY26 vs ₹156.36 crore in FY25. It showed an increase of 61.29% on a year-on-year basis.
  • Net Profit: AstraZeneca Pharma Ind reported a net profit of ₹187.52 crore in FY26 vs ₹115.74 crore in FY25. It showed an increase of 62.02% on a yearly basis.

AstraZeneca Pharma Ind Quarterly Result Highlights

  • AstraZeneca Pharma Ind reported revenue of ₹744.22 crore in Sep 2026, compared with ₹692.02 crore in Jun 2026, representing an increase of 7.54% on a quarter-on-quarter (QoQ) basis.
  • AstraZeneca Pharma Ind reported an operating profit of ₹88.49 crore in Sep 2026, compared with ₹50.75 crore in Jun 2026, representing an increase of 74.36% on a quarter-on-quarter (QoQ) basis.
  • AstraZeneca Pharma Ind reported a profit of ₹62.33 crore in Sep 2026, compared with ₹37.93 crore in Jun 2026, reflecting an increase of 64.33% on a QoQ basis.
  • The earnings per share (EPS) of AstraZeneca Pharma Ind stood at ₹75.01 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
75.00%
FII
2.64%
Other DII
0.08%
Retail and other
15.27%
Mutual funds
7.01%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20252.71%
Mar 20262.78%
Jun 20262.68%
Sep 20262.64%

AstraZeneca Pharma Ind Investment Returns

1 day
+0.54%
1 week
+2.67%
1 month
+11.61%
1 year
-28.23%
3 years
+32.61%
5 years
+115.08%

AstraZeneca Pharma Ind Share Price History

AstraZeneca Pharma Ind share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
09 Nov 26
₹6,484.00 / ₹6,514.50
+0.54%
08 Nov 26
₹6,507.50 / ₹6,479.50
+1.66%
06 Nov 26
₹6,294.00 / ₹6,373.50
+1.26%
05 Nov 26
₹6,499.00 / ₹6,294.00
-1.16%
Show more

AstraZeneca Pharma Ind Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,275.58₹1,716.29₹1,295.53₹1,002.97
Other Income₹28.49₹40.63₹34.80₹26.10
Total Revenue₹2,304.07₹1,756.92₹1,330.33₹1,029.07
Total Expenses₹2,046.62₹1,503.77₹1,127.22₹854.74
Profit Before Tax₹252.20₹156.36₹219.54₹134.10
Tax₹64.68₹40.62₹58.03₹34.81
Profit After Tax₹187.52₹115.74₹161.51₹99.29
EPS - Basic₹75.01₹46.30₹64.60₹39.70
EPS - Diluted₹75.01₹46.30₹64.60₹39.70

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹252.20₹156.36₹219.54₹134.10
Income before WC changes₹285.55₹232.77₹212.47₹129.30
Change in Assets-₹503.30-₹385.82-₹95.73-₹80.09
Change in Liabilities₹285.92₹282.60-₹32.44₹49.90
Change in WC-₹217.38-₹103.22-₹128.17-₹30.19
Cash flow from Operations-₹15.14₹65.36₹27.87₹58.29
Cash flow from Investing₹18.69₹30.80₹21.74₹18.11
Cash flow from Financing-₹91.97-₹65.59-₹44.38-₹24.48
Total Cash Flow-₹88.42₹30.57₹5.23₹51.92
Cash (Start of the year)₹536.14₹505.57₹500.34₹448.42
Cash (End of the year)₹447.72₹536.14₹505.57₹500.34

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹249.17₹175.77₹145.32₹149.40
Current Assets₹1,739.93₹1,342.35₹932.71₹835.47
Total Assets₹1,989.10₹1,518.12₹1,078.03₹984.87
Current Liabilities₹981.81₹703.00₹357.12₹383.93
Net Current Asset₹758.12₹639.35₹575.59₹451.54
Non-Current Liabilities₹134.50₹44.77₹8.99₹12.25
Equity Capital₹872.79₹770.35₹711.92₹588.69
Total Equity & Liabilities₹1,989.10₹1,518.12₹1,078.03₹984.87
* All values are in INR Crore
AstraZeneca Pharma Ind market depth
Bid quantityBid priceAsk priceAsk quantity
36514.500
0000
0000
0000
0000
Total bid quantity3
Total ask quantity0
AstraZeneca Pharma Ind technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
61.84
Neutral
ATR (14)
206.82
Neutral
STOCH(9,6)
54.6
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
48.38
Bearish
UO(9)
42.51
Neutral
ROC(12)
8.78
Bullish
WillR(14)
-30.14
Neutral
Period
Simple value
Exponential vaue
5D
6405.9
6424.18
10D
6356.65
6347.19
20D
6181.75
6281.77
50D
6392.15
6508.93
100D
7205.59
7000.73
Volume trend — traded volume by day
9 Nov0L
8 Nov0L
6 Nov0L
5 Nov0L
4 Nov0L
3 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

AstraZeneca Pharma Ind
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in AstraZeneca Pharma Ind

Fund name
AUM
Baroda BNP Paribas Health and Wellness Fund
4.07%
Bandhan Innovation Fund
3.90%
ICICI Prudential Quality Fund
2.84%

AstraZeneca Pharma Ind Returns Calculator

Ex-date: 31 Jul 2026

Top Gainers

CHEMPLASTS Share Price
₹237.83
+24.42 (+11.44%)
DATAPATTNS Share Price
₹4025.00
+321 (+8.67%)
QUESS Share Price
₹345.70
+27.15 (+8.52%)
SPARC Share Price
₹210.80
+13.77 (+6.99%)
GLAXO Share Price
₹2710.00
+170.4 (+6.71%)
See more

Top Losers

RRKABEL Share Price
₹1969.40
-146 (-6.9%)
FINCABLES Share Price
₹1232.40
-76.6 (-5.85%)
ALIVUS Share Price
₹1474.40
-84.3 (-5.41%)
TTML Share Price
₹39.33
-2.18 (-5.25%)
STLTECH Share Price
₹670.95
-35.3 (-5%)
See more

AstraZeneca Pharma Ind Share Price FAQs

Please be aware that AstraZeneca Pharma Ind stock prices are subject to continuous fluctuations due to various factors.